BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17847004)

  • 1. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.
    Milet J; Dehais V; Bourgain C; Jouanolle AM; Mosser A; Perrin M; Morcet J; Brissot P; David V; Deugnier Y; Mosser J
    Am J Hum Genet; 2007 Oct; 81(4):799-807. PubMed ID: 17847004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study.
    Milet J; Le Gac G; Scotet V; Gourlaouen I; Thèze C; Mosser J; Bourgain C; Deugnier Y; Férec C
    Blood Cells Mol Dis; 2010 Jan; 44(1):34-7. PubMed ID: 19879168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
    Radio FC; Majore S; Aurizi C; Sorge F; Biolcati G; Bernabini S; Giotti I; Torricelli F; Giannarelli D; De Bernardo C; Grammatico P
    Blood Cells Mol Dis; 2015 Jun; 55(1):71-5. PubMed ID: 25976471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
    Pelucchi S; Mariani R; Calza S; Fracanzani AL; Modignani GL; Bertola F; Busti F; Trombini P; Fraquelli M; Forni GL; Girelli D; Fargion S; Specchia C; Piperno A
    Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.
    Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H
    Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.
    Truksa J; Peng H; Lee P; Beutler E
    Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10289-10293. PubMed ID: 16801541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
    Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
    Barton JC; Lafreniere SA; Leiendecker-Foster C; Li H; Acton RT; Press RD; Eckfeldt JH
    Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype.
    Le Gac G; Scotet V; Ka C; Gourlaouen I; Bryckaert L; Jacolot S; Mura C; Férec C
    Hum Mol Genet; 2004 Sep; 13(17):1913-8. PubMed ID: 15254010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.
    Allen KJ; Bertalli NA; Osborne NJ; Constantine CC; Delatycki MB; Nisselle AE; Nicoll AJ; Gertig DM; McLaren CE; Giles GG; Hopper JL; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    Hepatology; 2010 Sep; 52(3):925-33. PubMed ID: 20583211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network.
    Gallego CJ; Burt A; Sundaresan AS; Ye Z; Shaw C; Crosslin DR; Crane PK; Fullerton SM; Hansen K; Carrell D; Kuivaniemi H; Derr K; de Andrade M; McCarty CA; Kitchner TE; Ragon BK; Stallings SC; Papa G; Bochenek J; Smith ME; Aufox SA; Pacheco JA; Patel V; Friesema EM; Erwin AL; Gottesman O; Gerhard GS; Ritchie M; Motulsky AG; Kullo IJ; Larson EB; Tromp G; Brilliant MH; Bottinger E; Denny JC; Roden DM; Williams MS; Jarvik GP
    Am J Hum Genet; 2015 Oct; 97(4):512-20. PubMed ID: 26365338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
    Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
    de Tayrac M; Roth MP; Jouanolle AM; Coppin H; le Gac G; Piperno A; Férec C; Pelucchi S; Scotet V; Bardou-Jacquet E; Ropert M; Bouvet R; Génin E; Mosser J; Deugnier Y
    J Hepatol; 2015 Mar; 62(3):664-72. PubMed ID: 25457201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-
    Lv T; Zhang W; Xu A; Li Y; Zhou D; Zhang B; Li X; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Xu H; Zheng J; Zhao R; Zhu L; Dong Y; Lu L; Chen Y; Long J; Zheng S; Wang W; You H; Jia J; Ou X; Huang J
    J Med Genet; 2018 Oct; 55(10):650-660. PubMed ID: 30166352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying factors of the HFE hemochromatosis phenotype.
    Deugnier Y; Mosser J
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):531-40. PubMed ID: 19072401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
    Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K
    J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.